Michael Aregger

Has grant

NIH Stadtman Investigator

National Institutes of Health
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Mapping genetic interactions in patient-derived cancer models to uncover novel therapeutic targets for Renal Cell Carcinomas

Open Date: 2022-10-01

Close Date: 2024-10-01

Grant: Close

Identification of genetic networks required for reprogramming of cancer cells in response to metabolic stress using next-generation CRISPR-Cas9 screens

Open Date: 2016-01-01

Close Date: 2017-06-30

Grant: Close

Systemic analysis of the gene expression reprogramming induced by environmental stress in cancer cells

Open Date: 2014-07-01

Close Date: 2015-12-31

Articles (6)

Year:

2026

Alternative splicing is a pervasive gene regulatory mechanism critical for diversifying the human proteome. To systematically investigate its role in cell fate determination, we develop scCHyMErA-Seq, a scalable CRISPR-based exon deletion screening platform integrated with 10x Genomics single-cell transcriptomic readouts. This tool enables efficient exon deletion while simultaneously capturing Cas9/Cas12a guides and polyadenylated transcripts at single-cell resolution. Applying scCHyMErA-Seq to high-throughput profiling of alternative cassette exons, we identify numerous exons with pronounced regulatory effects on gene expression and cell cycle progression. Analysis of the alternative NRF1 exon-7 demonstrates that its inclusion modulates NRF1’s regulatory function by influencing its recruitment to the promoters of target genes. Importantly, gene expression profiles generated using scCHyMErA-Seq accurately recapitulate findings from traditional, labor-intensive orthogonal methods, while offering enhanced scalability and efficiency. Overall, scCHyMErA-Seq represents a versatile platform for systematically unraveling the functional impact of alternative splicing by directly linking specific splicing variants to transcriptional phenotypes.

Year:

2026

Genetic interaction (GI) networks in model organisms have revealed how combinations of genome variants can impact phenotypes. To advance efforts toward a reference human GI network, we developed the q uantitative G enetic Interaction (qGI) score, a method for precise GI measurement from genome-wide CRISPR-Cas9 screens in different query mutants constructed in a single human cell line. We found surprising prevalent systematic variation unrelated to GIs in CRISPR screen data, including both genomically linked effects and functionally coherent covariation. Leveraging ∼40 control screens in wild-type cells and half a billion differential fitness effect measurements, we developed a pipeline for CRISPR screen data processing and normalization to correct these artifacts and measure accurate, quantitative GIs. We also comprehensively characterized GI reproducibility by characterizing 4 – 5 biological replicates for ∼125,000 unique gene pairs. The qGI framework enables systematic identification of human GIs and provides broadly applicable strategies for analyzing context-specific CRISPR screen data.

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Collaborators (14)

Maximilian Billmann

Assistant Professor

University Hospital Bonn

GERMANY
View details

Charles Boone

Professor

University of Toronto

CANADA
View details

Steve Cappell

Principle Investigator

National Cancer Institute

UNITED STATES
View details

Dae-Kyum Kim

Associate Member

Roswell Park Comprehensive Cancer Center

UNITED STATES
View details

Jason Moffat

Senior Scientist and Program Head

Hospital for Sick Children

CANADA
View details

Scott Dixon

Associate Professor

Stanford University

UNITED STATES
View details

Kevin Lin

University of Minnesota

UNITED STATES
View details

Chad L Myers

Professor

University of Minnesota

UNITED STATES
View details

Brenda J Andrews

University of Toronto

CANADA
View details

Thomas Gonatopoulos-Pournatzis

NIH Stadtman Investigator

National Institutes of Health

UNITED STATES
View details

Alexendar Perez

University of California, San Francisco

UNITED STATES
View details

Wen Wang

Researchers, Research Professional 5

University of Minnesota

UNITED STATES
View details

James Anthony Cornwell

National Institutes of Health

UNITED STATES
View details

Jolanda van Leeuwen

Associate professor

University of Massachusetts Chan Medical School

UNITED STATES
View details